Stem Cell Tracker: Stem Cell News Headlines 6/29

The market opened up and held the gains through the day. Stem cell stocks were half up, half down.

Directors of the California stem cell agency tomorrow will examine proposals from five financial firms that appear to be seeking millions of dollars to basically run the agency's ambitious and unprecedented $500 million biotech lending program.

Stem Cells Curing Cancer - 6.29.09

“After six months I went in for a second set of implants and after three or four months, I went in for another mammogram and was cancer free”, Lisa informed. The implants not only freed her from cancer, but her mental well being has done a completed 360.

The biotech industry was headed into the Valley of Death, after all, not a pleasant-sounding place to go looking for up-and-coming companies boldly pursuing their destinies.

Dr. Roberto Fernandez Vina is scheduled to present a stem cell research study in which he helped improve Diabetes Type 2 patients with their own Adult Stem Cells and followed up on them for 3 years! The stem cell treatment and therapy was a great success.

Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that the company was awarded a $1.9 million government grant from the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labor of Israel, as a government participation in R&D expenses for the period March 2009 to February 2010.

Advancements in stem cell research may one day help surgeons provide treatment for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, a deadly neurodegenerative disease characterized by the selective death of motor neurons.

New York State regulators have agreed to permit the use of state money to pay women who donate eggs for embryonic-stem-cell research, sensing an opportunity to push their universities into national leadership in the field

Cancer stem cells, which are the dangerous cells that resist modern treatments, may hold the key to to changing cancer treatments in the future, say scientists at the University of Rochester Medical Center.

Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN), a San Diego-based biotechnology company, announced today the launch of a national marketing program aimed at hospitals in need of storing umbilical cord blood specimens for future transplantation. The firm’s state-of-the-art 15,000 square foot cryogenic banking and processing facility serves a niche in the “storage” of adult stem cells from umbilical cord blood of patient donors’ specimens

Stem Cell Research for COPD and Emphysema Dr. Roberto Fernandez Vina will present his stem cell study on Chronic Obstructive Pulmonary Disease (COPD) and Emphysema next week at the International Society for Stem Cell Research (ISSCR) annual meeting in Barcelona, Spain

University of Missouri researchers have become some of the first in the world to transform connective tissue cells from a pig into stem cells capable of becoming any part of the anatomy.

A Baton Rouge mother is trying to raise the $60,000 it will take to pay for a specialized stem cell surgery overseas that may be able to restore her four-year-old daughter's sight.

Stem cell option - 6.29.09

Stem cells from umbilical cord blood is fast emerging as a treatment option for those suffering from thalassaemia, writes SUZANNA PILLAY.

"The first and most important investment in your baby's future health," counsels CorCell. "Your love and cord blood are two of nature's most powerful protectors," assures FamilyCord.

Employer:
    The University of Nottingham
Website:
http://www.nottingham.ac.uk
Location:
    Nottingham, UK
Posted:
    June 29, 2009
Expires:
    July 29, 2009

Blog Buzz